Mirion Technologies, Inc. (NYSE:MIR) Given Consensus Recommendation of “Moderate Buy” by Analysts

Mirion Technologies, Inc. (NYSE:MIR) has earned an average recommendation of “Moderate Buy” from the nine brokerages that are covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $27.6250.

Several brokerages recently issued reports on MIR. The Goldman Sachs Group dropped their target price on shares of Mirion Technologies from $33.00 to $29.00 and set a “buy” rating on the stock in a report on Thursday, February 12th. Evercore began coverage on shares of Mirion Technologies in a research note on Tuesday, November 25th. They set an “outperform” rating and a $29.00 target price for the company. Morgan Stanley lowered their price target on Mirion Technologies from $29.00 to $27.00 and set an “equal weight” rating on the stock in a report on Wednesday, March 11th. JPMorgan Chase & Co. dropped their price target on Mirion Technologies from $33.00 to $30.00 and set an “overweight” rating on the stock in a research note on Monday, March 9th. Finally, Citigroup cut their price objective on Mirion Technologies from $32.00 to $29.00 and set a “buy” rating for the company in a report on Thursday, February 12th.

Hedge Funds Weigh In On Mirion Technologies

Institutional investors have recently made changes to their positions in the business. Tudor Investment Corp ET AL increased its holdings in Mirion Technologies by 174,900.0% during the third quarter. Tudor Investment Corp ET AL now owns 17,500,000 shares of the company’s stock valued at $407,050,000 after buying an additional 17,490,000 shares during the last quarter. Vanguard Group Inc. boosted its stake in shares of Mirion Technologies by 28.0% during the 3rd quarter. Vanguard Group Inc. now owns 30,418,327 shares of the company’s stock worth $707,530,000 after acquiring an additional 6,651,735 shares during the last quarter. Two Creeks Capital Management LP bought a new stake in shares of Mirion Technologies during the 3rd quarter valued at $83,707,000. UBS Group AG grew its position in shares of Mirion Technologies by 181.4% during the 3rd quarter. UBS Group AG now owns 4,796,833 shares of the company’s stock valued at $111,574,000 after acquiring an additional 3,092,136 shares during the period. Finally, TCW Group Inc. purchased a new stake in shares of Mirion Technologies in the 4th quarter worth $57,439,000. Institutional investors own 78.51% of the company’s stock.

Mirion Technologies Price Performance

MIR opened at $18.46 on Friday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.34 and a current ratio of 2.83. The stock has a market capitalization of $4.62 billion, a P/E ratio of 167.79 and a beta of 0.99. The company’s 50-day simple moving average is $22.97 and its two-hundred day simple moving average is $23.94. Mirion Technologies has a 52-week low of $12.00 and a 52-week high of $30.28.

Mirion Technologies (NYSE:MIR) last announced its quarterly earnings results on Tuesday, February 10th. The company reported $0.15 EPS for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.01). Mirion Technologies had a return on equity of 6.97% and a net margin of 3.11%.The company had revenue of $277.40 million during the quarter, compared to the consensus estimate of $281.17 million. During the same quarter in the prior year, the firm earned $0.17 earnings per share. The business’s revenue was up 9.1% compared to the same quarter last year. Mirion Technologies has set its FY 2026 guidance at 0.500-0.570 EPS. As a group, analysts predict that Mirion Technologies will post 0.39 EPS for the current year.

Mirion Technologies Company Profile

Mirion Technologies Inc (NYSE: MIR) is a leading global provider of radiation detection, measurement and monitoring solutions. The company’s portfolio includes instrumentation, software and service offerings designed to detect, quantify and manage radiation in nuclear power, oil and gas, defense and homeland security, medical imaging and diagnostic applications. Mirion’s product suite spans personal and environmental dosimetry, area monitors, digital imaging detectors and turnkey solutions for decommissioning and environmental remediation projects.

Mirion traces its origins to the combination of several established radiation measurement businesses, including the former Canberra nuclear instrumentation division, and has been supported by private equity investors before completing its initial public offering on the New York Stock Exchange in 2023.